MARGARET PULLIN: Open Payments
NPI 1740809961 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,804 in 167 payments from 18 companies in 2025. Trend: 2023 $4,724 · 2024 $2,802 · 2025 $6,804
Speaker / faculty: $3,300Food & beverage: $2,768Consulting: $736
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 19 | $3,420 |
| E.R. Squibb & Sons, L.L.C. | 19 | $971 |
| ABBVIE INC. | 35 | $555 |
| Amgen Inc. | 25 | $499 |
| PFIZER INC. | 14 | $266 |
| Novartis Pharmaceuticals Corporation | 12 | $238 |
| UCB, Inc. | 9 | $234 |
| Lilly USA, LLC | 10 | $140 |
| AstraZeneca Pharmaceuticals LP | 5 | $99 |
| Genentech USA, Inc. | 3 | $70 |
Products named: BENLYSTA, RINVOQ, XELJANZ, SKYRIZI, ORENCIA, Bimzelx, COSENTYX, OTEZLA.
Industry payments across OH — which companies pay providers there.
